baber/WOPTO huggingface dataset:
Patent JP-H11504274-A (JP)
Title: エアーフレッシュナーおよび他の装置のための調節可能なクリップ手段
IPC: F16B2/20
Filed: 1996-04-24
Abstract: (57)【要約】
各種の位置で物品を取り付けることのできる、第１部分（１０）と第２部分（２０）とを有する調節可能なクリップ。その第１部分（１０）は背面（１４）と、その背面（１４）に対して約４０〜６０°の角度をなす第１の平坦面（１２）とを含む。第２部分（２０）は、クリップ手段（２４）およびそのクリップ手段（２４）の一端に取り付けられ、取り付けられる面に平行な線に対して約２０〜５０°の角度をなす平坦面（２２）と、前記２つの平坦面（１２と２２）が密接平行に配列され、かつ、前記クリップ手段（２４）が物品の背面に対して少なくとも２箇所で調節できるように、前記第１部分（１０）と前記第２部分（２０）とを回転可能に連結するための手段（２６）を有する。
Patent JP-H11504955-A (JP)
Title: 古い合成樹脂または廃棄合成樹脂の加工処理法
IPC: C10G1/00
Filed: 1996-05-02
Abstract: (57)【要約】
化学原料物質および液状燃料成分を得るために、古い合成樹脂または廃棄合成樹脂を高温で解重合してポンプ搬送可能な相並びに揮発性相にする。揮発性相は気相と凝縮液とに分離する。従来技術に比較してこの方法を合理化するために、揮発性相の分離後に残る解重合体を凝縮液または凝縮成分と一緒に水素の存在下に加圧下に加熱しそして非揮発性成分の分離後に合成粗原料を得るために水素化処理に付す。
Patent JP-H11506216-A (JP)
Title: 測定検出子のための接続導管
IPC: G01N27/407
Filed: 1996-11-20
Abstract: (57)【要約】
特に燃焼機関の排ガス中の酸素含有量を決定するための測定検出子が提案され、この測定検出子が、金属製のハウジング（１３，３０）内に配置されたセンサ素子（１４）を備えており、このセンサ素子が、ケーブル被覆（１２）により囲まれていてハウジング（１３，３０）から導出された接続ケーブル（１８）に接触接続されており、その場合、ハウジング（１３，３０）内に、センサ素子（１４）のための基準雰囲気が導入される。ケーブル被覆（１２）は外套面のところに少なくとも領域的に少なくとも１つの通気性の部分を備えており、この部分を介して基準雰囲気がケーブル被覆（１２）の内部へ、かつそこからハウジング（１３，３０）内へ達することができる。ケーブル被覆（１２）としては特に多孔性のＰＴＦＥ製のホースが適している。
Patent JP-2001511046-A (JP)
Title: ソフトシーケンスラッチを備えた入れ子式引出しスライド
IPC: A47B88/493
Filed: 1998-02-06
Abstract: (57)【要約】
引出しスライドと共に用いるのに適したシーケンスラッチである。このシーケンスラッチは摺動部材（２６）に保持されるラッチアーム（５１）と、第二摺動部材（４１）上のロック要素（７７）と係合するようにラッチアームを付勢する摺動部材と圧縮状態で接触するラッチアームから延びるバネアーム（６３）と、ラッチアームを係合解除するための第三摺動部材（１１）上のアクチュエータ（９１）とを具備する。アクチュエータは互いに反対方向を向いた成分を有するラッチアームの力にバネの圧縮力に勝るのに十分な大きさで適用することによりラッチアームを係合解除する。ロック要素とラッチアームとの相互作用およびアクチュエータとラッチアームとの相互作用は両方とも摺動動作中における摩擦界面として機能可能である。
Patent JP-2001511757-A (JP)
IPC: B66B9/08
Filed: 1998-02-20
Abstract: The inclination of a structure A eg the seat of a stair lift is measured using an inclinometer attached to the structure comprising an arm section B carrying a strain measuring sensor C. An inertial mass O is attached to the end of the arm section B and any deviation in inclination of the structure results in strain being detected by the measuring element C. The inertial mass comprises a ring of material which is free to rotate about the axis of the bearing about which the seat frame rotates relative to the chassis. The output of the sensor is used to maintain the seat in a horizonal position at all times.
Patent JP-2001519098-A (JP)
Title: レーザ変調制御法およびその装置
IPC: H01S5/0683
Filed: 1998-03-17
Abstract: (57)【要約】
半導体レーザの伝達消光比の直接制御を行うレーザ変調制御装置とその方法。比較的低い周波数でかつ小さな振幅であるパイロット・トーンは、レーザを駆動するために使用される信号上に重ね合わされる。レーザ変調電流の固定した部分にパイロット・トーンの振幅を設定することで、パイロット・トーン周波数で光データ振幅の固定した部分を変化させる伝達光学パワーを発生させる。レーザ変調電流を制御するフィードバックを使用することにより、動作温度もしくはレーザの老化による変動にかかわらず、変化の振幅は所望の値で保持され、次に、伝送光データ振幅を一定値で保持する。分離制御ループは、特定の値で平均光学パワーを保持するために使用される。光データ振幅と平均光パワーは、一定値のまま残るので、消光比も一定値になる。代替の実施形態が開示されている。
Patent JP-2001526813-A (JP)
Title: 基準ベースのパラメータ寸法決定方法及びシステム
IPC: G06F17/50
Filed: 1998-01-16
Abstract: (57)【要約】
記述されているＣＡＤシステムは、ＣＡＤ図面又はモデル内の１オブジェクトの物理的寸法を記述する寸法エンティティをドラフトマンが容易に入力できるようにする。寸法エンティティは、長さ、角度又は半径方向のいずれかの寸法を定義し、各々の寸法エンティティについて、ユーザーは、通常の寸法情報に付加して基準原点を定義する。定義された各々の寸法エンティティの値は、単純な定数、パラメータ又は多数の定数及びパラメータの表現式である可能性がある。付加された基準原点により、関連された寸法エンティティの非常に複雑なネットワークを簡単に定義し容易に修正することができる。寸法エンティティの再計算は、一般的ＣＡＤ図面又はモデルの大域空間からのエンティティグループを局所空間へと変換するパラメータ寸法決定エンジンによって実行される。局所空間内にある間に、パラメータ寸法決定は、エンティティの座標データを再計算する。
Patent NZ-199627-A (NZ)
Title: 1,4-diazine derivatives
Inventor: BARLOW J J
IPC: C07D405/12
Filed: 1982-02-01
Abstract: Novel alkanolamine derivatives of the formula: ArOCH2.CHOH.CH2NHA1NHCO  +TR <IMAGE>  wherein Ar is phenyl or naphthyl which is unsubstituted or which bears one or two substituents selected from halogen, trifluoromethyl, hydroxy, amino, nitro, carbamoyl, carbamoylmethyl and cyano, and alkyl, alkenyl, alkoxy, alkenyloxy, alkylthio, alkanoyl and alkanoylamino each of up to 6 carbon atoms, or Ar is 4-indolyl, 4-benzo[b]thienyl, 5-benzo[1,4]dioxanyl, 4- or 5-indanyl, 5- or 6- 1,2,3,4-tetrahydronaphthyl), 2,3-dihydroxy-1,2,3,4-tetrahydronaphth-5-yl or 4- morpholino-1,2,5-thiadiazol-3-yl; wherein R is halogen; wherein A1 is alkylene of 2 to 6 carbon atoms; and wherein A2 is alkylene of 1 to 7 carbon atoms which in unsubstituted or bears a phenyl, hydroxy or carbamoyl substituent, or A2 is cycloalkylene of 3 to 6 carbon atoms; or acid-addition salts thereof. The compounds possess either  beta -adrenergic blocking activity or diuretic activity or both such activities and may be used in the treatment of heart disease or hypertension. Also disclosed are processes for the manufacture of the compounds and pharmaceutical compositions containing them.
Patent NZ-213419-A (NZ)
Title: Concrete admixtures containing polyethyleneimine compounds
Inventor: TSUTOMU TERAJI
IPC: C04B24/26
Filed: 1985-09-10
Abstract: Concrete admixture comprising polyethyleneimine compounds selected from the group consisting of (1) poly[acidic group(s) and/or acidic group(s) substituted-alkyl group(s) and/or acidic group(s) substituted-acyl group(s)] polyethyleneimine and (2) poly[acidic group(s) substituted-alkyl and a group selected from the group consisting of carbamoylalkyl and hydroxy substituted-alkyl] polyethyleneimine, and use thereof as admixture in cementing composition for improving the flow properties.
Patent NZ-222542-A (NZ)
Title: Production of chimeric immunoglobulins, expression vectors and host cell
Inventor: CABILLY SHMUEL
IPC: C12N15/81
Filed: 1984-04-04
Abstract: Recombinant DNA techniques are used to produce both immunoglobulins which are analogous to those normally found in vertebrate systems and to take advantage of these gene modification techniques to construct chimeric or other modified forms.
Patent NZ-231480-A (NZ)
Title: Paste-form, low-foaming, non-phosphate detergent
Inventor: TRABITZSCH UWE
IPC: C11D3/08
Filed: 1989-11-22
Abstract: PCT No. PCT/EP89/01371 Sec. 371 Date May 24, 1991 Sec. 102(e) Date May 24, 1991 PCT Filed Nov. 15, 1989 PCT Pub. No. WO90/05773 PCT Pub. Date May 31, 1990.A paste-form, non-phosphate detergent which is particularly suitable for the washing of heavily soiled working apparel and which generates no troublesome foam essentially contains (A) 1 to 3% by weight sodium alkyl benzene sulfonate having linear C9-13 alkyl chains, (B) 14 to 18% by weight of a linear or 2-methyl-branched, saturated, primary C12-15 alcohol containing 2 to 4 ethylene glycol ether groups, (C) 12 to 16% by weight of a linear or 2-methyl-branched, saturated, primary C12-15 alcohol containing 6 to 8 ethylene glycol ether groups, (D) 50 to 65% by weight sodium silicate having the composition Na2O:SiO2=1:0.8 to 1:1.5, (E) 2 to 8% by weight, based on sodium salt, of at least one complexing agent from the group consisting of nitrilotriacetic acid and polyphosphonic acids, (F) 0.5 to 2.5% by weight water-soluble polymers having a redeposition-inhibiting effect, (G) 0 to 5% by weight other nonsurfactant and non-builder detergent constituents and (H) less than 4% by weight water. The paste can be introduced into washing machines by automatic dispensing systems.
Patent NZ-239133-A (NZ)
Title: Drug delivery system comprising an active covalently bonded to a polymer - the covalent bond being cleavable in an acid ph
Inventor: TREMONT SAMUAL J
IPC: A61K47/48
Filed: 1991-07-25
Abstract: Cross-linked controlled density polyamines which are water-insoluble and swell at pH values up to about 8 are shown. These polyamines are useful in site-specific drug delivery systems.
Patent NZ-245388-A (NZ)
Title: Dewatering sludge by treating waste water with agglutinating agent
Inventor: HACHIRO SATO
IPC: C02F11/12
Filed: 1992-12-07
Abstract: In a method of dewatering sludge wastes discharged from a factory such as pulp factory, sludge wastes are first dewatered by a preliminary dewatering device such as a pre-thickener of a rotary screen type, a sludge discharged from the preliminary dewatering device is then supplied to a main dewatering device such as a screw press. Waste liquids discharged from the preliminary and main dewatering devices are supplied to an agglutinating reaction tank together with a macromolecular agglutinating reagent and agglutinated substances in the agglutinating reaction tank are treated by the main dewatering device. The agglutinated substances formed on the bottom surface of the agglutinating reaction tank may be treated by a different main dewatering device than said main dewatering device. A necessary amount of the macromolecular agglutinating reagent to be supplied to the agglutinating reaction tank can be reduced, while the dewatering efficiency is not deteriorated. <IMAGE>
Patent NZ-255977-A (NZ)
Title: Germicidal air filter using u/v radiation and a filter medium
Inventor: FANNIN KERBY
IPC: F24F7/00
Filed: 1993-09-23
Abstract: A germicidal air purifier for trapping and destroying airborne microorganisms is disclosed. The air purifier includes an ultraviolet radiation source and a juxtaposed filter medium. A one of the ultraviolet radiation source and the filter medium is fixed and the other is displaceable so that at least an upstream side of the filter medium is systematically exposed to germicidal levels of radiation. In a first preferred embodiment, a fixed ultraviolet lamp irradiates a cylindrical air filter which is rotated on its longitudinal axis in close proximity to the lamp so that the upstream side of the filter is systematically irradiated. In a second preferred embodiment, a radiant lamp fixture is moved reciprocally across an upstream side of a planar filter to systematically irradiate the filter. In a third preferred embodiment, a radiant lamp fixture is rotated about an axis which is orthogonal to its longitudinal midpoint so that a circular area of a planar filter is irradiated. The advantage is that microorganisms trapped on the filters are exposed to a lethal dose of radiation and the air purifier is consistently effective at destroying a significant percentage of airborne microorganisms suspended in air passed through the filter.
Patent NZ-257927-A (NZ)
Title: Absorbent structure in an absorbent article - cellulose fibres compressed, softened and delaminated to form partially separated layers
Inventor: OSTERDAHL EJE
IPC: D04H1/425
Filed: 1993-11-15
Abstract: A method of producing an absorbent structure in an absorbent article includes the steps of compressing an air laid web of cellulose fibers into a dry-formed sheet having a first density of between 0.2-1.0 g/cm2 and mechanically softening the compressed sheet by a noncutting method to a second density, which is lower than the first density, whereby the sheet is delaminated so as to form a plurality of partially separated thin fiber layers, each of which layers exhibits a density which corresponds to the first density.
Patent NZ-258210-A (NZ)
Title: Syringe with a plurality of chambers
Inventor: HIGASHIKAWA TETSURO
IPC: A61M5/28
Filed: 1993-11-30
Abstract: When an emergency medical care is required and when it is necessary to inject a plurality of medicines at a time or to dissolve a solid pharmaceutical in a solution before the injection, different types of injections are placed in chambers separately formed in a cylinder without previously being mixed up and, when to be injected, both types of the injections are successively dispensed by a simple means or are mixed up. <MATH>
Patent NZ-279238-A (NZ)
Title: Microgranules containing 5-nitro-imidazole derivatives, mixtures of gastroresistant and prolonged-release microgranules, and medicaments thereof
Inventor: LEDUC GERARD
IPC: A61K31/415
Filed: 1995-01-12
Abstract: Medicinal form contains a combination of microgranules of derivatives 5-nitroimidasole, consisting, on the one hand, of gastro-resistant microgranules and, on the other hand, of microgranules with a prolonged release of a medicinal agent. Gastroresistant microgranules are intended to guarantee the efficiency of the medicinal form of the present invention, primarily, in the upper part of gastrointestinal tract, while the microgranules with a prolonged medicinal agent release are operate mainly in the lower part of gastrointestinal tract.
Patent NZ-301622-A (NZ)
Title: Fabric blind slat with at least one longitudinal pocket
Inventor: ZORBAS TASS
IPC: E06B9/302
Filed: 1996-02-28
Abstract: The present invention relates to a fabric blind slat and a fabric venetian blind assembly; the fabric blind slat includes an elongated strip of fabric characterized in that the strip of fabric has at least one longitudinally extending pocket on a longitudinal edge into which a relatively rigid support member is insertable.
Patent NZ-307151-A (NZ)
Title: Instruments for the adjustment osteotomy of a lower extremity, surgical saw guides
Inventor: WEHRLI ULRICH
IPC: A61B17/14
Filed: 1996-05-21
Abstract: PCT No. PCT/CH96/00195 Sec. 371 Date Aug. 29, 1997 Sec. 102(e) Date Aug. 29, 1997 PCT Filed May 21, 1996 PCT Pub. No. WO96/37154 PCT Pub. Date Nov. 28, 1996An instrument for performing a correctional osteotomy of a lower extremity of a patient has a securing frame (1), fixation elements (7, 8) for attaching the frame to the skeleton of the lower extremity of the patient, and securing components (6, 9) adjustably holding the fixation elements on the frame. A saw guide (25) is mounted on said frame so as to be angularly adjustable relative to the frame. An angle-indicating scale plate (10) is adjustably attached to one of the securing components. A rotation axis pin (12) penetrates the scale plate and points toward a location on the skeleton for intersection of bone cuts to be made. An angle determining component (23) is pivotable about the rotation axis pin and carries the saw guide and two pointers (26, 27) aligned with each other and alignable with a projection of a mechanical loading axis of the extremity of the patient, whereby adjustment of the pointers directly causes adjustment of the saw guide.
Patent NZ-332603-A (NZ)
Title: Black-head removing face pack sheet
Inventor: HOSHI MASARU
Filed: 1998-03-20
Abstract: A blackhead-removing face pack sheet and method of manufacture is described.  The pack is formed from a laminate comprising a flexible, gas-permeable base layer, preferably fibrous, and a pack material layer containing a copolymer (10-50 kDa) of vinyl acetate and N-vinyl-2-pyrrolidone in a 5:95 to 95:5 ratio respectively.
Patent NZ-333197-A (NZ)
Title: Polymorphs of donepezil hydrochloride
Inventor: IMAI AKIO
IPC: C07D211/32
Filed: 1997-06-06
Abstract: Donepezil hydrochloride, 1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]methlypiperidine hydrochloride, is provided in the form of four polymorphs which are stable against heat and humidity. They are specified by peaks in X-ray powder diffraction pattern and absorption peaks in infrared absorption spectra in potassium bromide.
Patent NZ-333321-A (NZ)
Title: Needle for subcutaneous delivery of fluids, slots in needle near tip
Inventor: GROSS JOSEPH
IPC: A61M5/20
Filed: 1997-06-04
Abstract: A needle, used in delivering liquid to a subject includes a bore 15 open at one end 13, and sharpened at the other end 19.  The needle has one or more transverse linear cuts 18.  These slots have angled sides as shown, and may be mass produced by passing a grinding wheel across a row of needles.  The slots ensure that liquid is delivered to a large surface area of tissue to improve absorption and reduce fluctuations in the delivery rate.
Patent NZ-334970-A (NZ)
Title: Human growth gene and short stature gene region using sequence derived from the SHOX gene
Inventor: RAO ERCOLE
IPC: C12Q1/02
Filed: 1997-09-29
Abstract: An isolated human nucleic acid molecule encoding polypeptides containing a homeobox domain of sixty amino acids having the amino acid sequence of SEQ ID NO:1 and having regulating activity on human growth. Three genes residing within about 500 Kb short stature critical regions on the X and Y chromosome were identified. At least one of these genes is responsible for the short stature phenotype. The cDNA corresponding to this gene may be used in diagnostic tools to further characterise the molecular basis for the short stature-phenotype. In addition, the identification of the gene product of the gene provides a method for the development of superior therapies for short stature.
Patent NZ-335584-A (NZ)
Title: Water miscible composition containing a solvating solvent and a biocidal biologically active agent
Inventor: NOWAK MILTON
IPC: A01N25/04
Filed: 1997-10-29
Abstract: A water miscible biocidal composition suitable for forming a clear microemulsion, a clear micellar solution or a clear molecular solution comprises a single solvating surfactant selected from the group consisting of an alkoxylated castor oil, an alkoxylated hydrogenated castor oil and an alkoxylated rosin, and a biocidal biologically active material dissolved in the solvating surfactant.  The composition can further contain a co-solvent such as castor oil.  The biocidal biologically active material can be a) iodopropargyl butyl carbamate; b) benzisothiazolones; c) permethryn; d) terbutryn; e) propaconazole; f) tebuconazole; g) 8-hydroxyquinoline; h) propiconazole; i) deltamethrin; j) cypermethrin; k) chlorpyriphos; l) 2-(hydroxymethylamino) ethanol; m) iodopropynyl cyclohexyl carbamate; n) N-cyclopropynyl-N1 -(1,1-dimethylethyl)-6-(methylthio)-1,3,5-triazine-2,4-diamine; o) 2,4-dichloro phenoxyacetic acid, butyl ester; p) 2,4,5-trichlorophenoxy acetic acid, ethyl ester; q) 2,4 dichlorobutyric acid, ethyl ester; r) chlordane; s) piperonyl butoxide; t) bromoxynil; u) isobornylthiocyanoacetate; v) iodopropargyl succinate; w) 5-chloro-2-methyl-4-isothiazolin-3-one; x) 2-methyl-4-isothiazolin-3-one; y) 1,4 -dichloro-2,5-dimethoxy benzene; z) orthophenylphenol; aa) azaconazole; bb) cyperconazole; cc) diiodomethyl-p-tolyl sulphone; dd) iodopropynyl phenylether; ee) cyfluthrin; ff) beta cyfluthrin; gg) lambda-cyhalothrin; hh) cyhexatin; ii) cyphenothrin; jj) endosulfan; kk) (1,4,5,6,7,7-hexachloro 8,9,10-trinorborn-5-en-2,3-ylene bismethylene) sulphide and ll) fenitrothion.
Patent NZ-336126-A (NZ)
Title: Electronically controlled lock locking member biased towards locked position
Inventor: KUNG OTTO
IPC: E05B27/00
Filed: 1997-12-08
Abstract: A locking device has an electronically controlled locking element 2 that engages a rotor 1 with the stator 6 in a lock cylinder.  The locking element is moved between a locked position xS and a free position xF in a positively controlled way by the electric motor 9 driving the helical drive 53 that transfers motion to the element 2 via the actuator 4.  The element 2 is biased towards the locked position by, for example, spring 3 when it is in the free position or a neutral position x0.  The rotor 1 is locked by the element 2 whenever the element 2 is not in the free position.  This arrangement is said to make it more difficult to unlock the rotor by applying vibrations or magnetic fields to the lock.
Patent NZ-505766-A (NZ)
Title: Triazole and imidazole derivatives bearing 2 phenyl rings and their use for treating NMDA mediated conditions
Inventor: ALANINE ALEXANDER
IPC: A61P25/28
Filed: 2000-07-17
Abstract: The compound of formula I (and salts thereof) wherein: R1-R4 are H, -CF3, -OCF3, -OCHF2, -OCH2F, alkyl, alkoxy, halogen, hydroxy, phenyl, benzyl, amino, nitro, pyrrol-1-yl, alkylsulfonyl, alkylsulfanyl, cyano or benzyloxy; or R2 and R3 together are -O-(CH2)2-O-, -O-CH2-O-, -O-(CH2)2-, -(CH2)3- or -CH=CH-CH=CH-; X is -N=, -N(R8)- or -CH=; Y is -N=, =N-, -N(R8) or -CH=; wherein one of X or Y has to be nitrogen R5 is a group of formula II wherein: R6 and R7 are H, alkyl, -C(O)-alkyl, hydroxyalkyl, alkenyl, or -C(O)CH2OH; or R6 and R7 together are -(CH2)n-, -(CH2)2-O-(CH2)2-, -CH2-CH=CH-CH2-, CH2CH[OC(O)CH3]-(CH2)2, -CH2-CH[NHC(O)CH3]-(CH2)2, -O-(CH2)3-, -CH2-CH(OCH3)-(CH2)2-, -CH2-CH(halogen)-(CH2)2-, -(CH2)2CH(O-phenyl)-(CH2)2-, -(CH2)2-N(CHO)-(CH2)2-, -(CH2)2-N(COCH3)-(CH2)2-, -CH2-CH(OH)-(CH2)3-, -(CH2)2-CH(OH)-(CH2)2- or -(CH2)2-N(benzyl)-(CH2)2; n is 3-5  R8 is H, alkyl, alkenyl, alkynyl, -(CH2)m-O-alkyl, -(CH2)m-OH, -(CH2)m-CHF2, -(CH2)m-CH2F, -(CH2)m-C(O)-alkyl, -(CH2)m-C(O)O-alkyl, -(CH2)m-CH(OH)-alkyl, -(CH2)m-CH(OH)-(CH2)mOH, -(CH2)m-C6H5, which phenyl ring is optionally substituted by alkyl, alkoxy or hydroxy, -(CH2)m-C(=CH2)-alkyl, -(CH2)m-cycloalkyl, -(CH2)m-CN, -(CH2)m-pyridin-4-yl, -(CH2)m-pyridin-3-yl or -(CH2)m-pyridin-2-yl; m is 0 to 4. Also described is a medicament containing one or more compounds of formula I (or salts thereof) for the treatment of diseases, especially for the treatment or prophylaxis of diseases caused by overreaction of respective NMDA receptor subtypes. The compounds of formula I are useful for the treatment or prophylaxis of diseases caused by overactivation of respective NMDA receptor subtypes, which include acute forms of neurodegeneration (caused for example by stroke or brain tumour), for treating chronic forms of neurodegeneration (such as Alzheimer's disease, Parkinson's disease, Huntington's disease or amyotrophic lateral schlerosis), for treating neurodegeneration associated with bacterial or viral infections or for treating diseases such as schizophrenia, anxiety, depression and acute/chronic pain.
Patent NZ-510377-A (NZ)
Title: High strength aqueous glyphosate concentrate comprising the potassium salt of glyphosate with alkylglycoside and alkoxylated alkylamine surfactants
Inventor: BEAN MICHAEL JOHN
IPC: A01N25/30
Filed: 1999-08-18
Abstract: A storage-stable high-strength aqueous glyphosate concentrate containing greater than 400 g/l glyphosate expressed as acid is described.  The aqueous concentrate comprises the potassium salt of glyphosate, an alkylglycoside surfactant and an alkoxylated alkylamine surfactant at a total concentration of alkylglycoside and alkoxylated alkylamine from 160 to 300 g/l and at a ratio of alkylglycoside to alkoxylated alkylamine of from 1 part by weight alkylglycoside per 1 part alkoxylated alkylamine to 5 parts of alkylglycoside per 1 part alkoxylated alkylamine.
Patent NZ-510779-A (NZ)
Title: Ureidopiperidine derivatives useful as selective human NK 3 receptor antagonists
Inventor: AULOMBARD ALAIN
IPC: C07D211/26
Filed: 1999-10-04
Abstract: A compound or a salt or solvate thereof has the formula (I) wherein: R1 and R2 are independently H or alkyl and R3 is H. The compound is useful for treating respiratory disorders, central nervous system disorders, pain and gastrointestinal system disorders.
Patent NZ-511567-A (NZ)
Title: Specific immune response to HIV enhanced by vaccination with recombinant avipox virus construct comprising HIV gag/pol nucleotide sequences and the cytokine gamma interferon
Inventor: RAMSHAW IAN ALLISTER
IPC: A61K35/76
Filed: 1999-11-09
Abstract: The  present invention relates generally to  fowl  pox virus encoding an HIV antigen (gag and/or pol) expressing  a protective   antigen  together  with   a   cytokine   (gamma interferon)  and  to vaccine compositions  comprising  same. In  particular,  described is a recombinant viral  construct capable  of  inducing an immune response to an  HIV  antigen and,  most  particularly, an HIV-1 antigen.  The composition is   useful,   inter   alia,  in  the   therapeutic   and/or prophylactic treatment of HIV.
Patent NZ-515990-A (NZ)
Title: Methods for making Apo-2 ligand using divalent metal ions
Inventor: ASHKENAZI AVI J
IPC: C12N15/09
Filed: 2000-06-26
Abstract: A formulation comprising Apo-2 ligand and one/more divalent metal ions, wherein the ions are present at less than 2x the molar ratio of the ligand. Also disclosed are isolated Apo-2 ligands.